A 2022 study estimates that at-home flu tests have a sensitivity of about 61% if the test is performed within 72 hours of ...

CoDiagnostics CODX recently announced that the Australian Patent Office has granted a patent covering its new Co-Dx PCR ...

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...

AI chatbot achieves high accuracy in performing clinical patient diagnostic interviews for common mental health disorders.

The Australian patent represents the first patent granted for the Company's new point-of-care testing platformSALT LAKE CITY, ...

WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.

On 17 December 2025, the World Health Organization (WHO) announced the prequalification of two rapid antigen diagnostic tests ...

The addition of Bako and StrataDx is anticipated to bolster Fulgent’s lab services business with the inclusion of new ...

Approaches incorporating rapid or digital PCR, CRISPR, syndromic testing, and multimodal systems reached new milestones this year.

According to Precedence Research, the global precision medicine market size is valued at USD 119.03 billion in 2025 and is ...

IntroductionThe global critical care diagnostics market is poised for steady expansion, projected to grow at a CAGR of around 6% over the next five years. This growth trajectory is supported by ...